GPX4 and ischemic stroke: Biomarkers validated in animal models—such as serum GPX4 activity and cerebrospinal fluid 4-HNE levels—show marked individual variability among ischemic stroke patients and are strongly influenced by reperfusion timing and comorbidities such as diabetes.